Close Menu

This article has been updated with information from Thermo Fisher's earnings conference call.

NEW YORK  – Thermo Fisher Scientific on Wednesday morning reported a 10 percent year-over-year boost in second quarter revenues, driven by increased global demand for COVID-19-related products and services.

The results are in line with the Waltham, Massachusetts-based company's earlier prediction of 10 percent revenue growth for Q2.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

NPR reports that some insect pests are now becoming resistant to Bt crops.

A 50-year-old cold case was cracked using genetic genealogy, the New York Times reports.

Science reports the US Food and Drug Administration did not consult an outside panel in its approval of remdesivir as a COVID-19 treatment.

In Nature this week: a framework for future human genomic research, PORE-cupine approach to study RNA structure using nanopore sequencing, and more.